Therapeutic potential of tumor treating fields for malignant brain tumors
Open Access
- 29 March 2023
- journal article
- review article
- Published by Wiley in Cancer Reports
- Vol. 6 (5)
Abstract
Background: Malignant brain tumors are among the most threatening diseases of the central nervous system, and despite increasingly updated treatments, the prognosis has not been improved. Tumor treating fields (TTFields) are an emerging approach in cancer treatment using intermediate‐frequency and low‐intensity electric field and can lead to the development of novel therapeutic options.Recent Findings: A series of biological processes induced by TTFields to exert anti‐cancer effects have been identified. Recent studies have shown that TTFields can alter the bioelectrical state of macromolecules and organelles involved in cancer biology. Massive alterations in cancer cell proteomics and transcriptomics caused by TTFields were related to cell biological processes as well as multiple organelle structures and activities. This review addresses the mechanisms of TTFields and recent advances in the application of TTFields therapy in malignant brain tumors, especially in glioblastoma (GBM).Conclusions: As a novel therapeutic strategy, TTFields have shown promising results in many clinical trials, especially in GBM, and continue to evolve. A growing number of patients with malignant brain tumors are being enrolled in ongoing clinical studies demonstrating that TTFields‐based combination therapies can improve treatment outcomes.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81725009, 21788102, 82030049)
This publication has 107 references indexed in Scilit:
- Tumor treating fields: a new frontier in cancer therapyAnnals of the New York Academy of Sciences, 2013
- The septin cytoskeleton facilitates membrane retraction during motility and blebbingJournal of Cell Biology, 2012
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupJournal of Clinical Oncology, 2010
- Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastomaNeurology, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungsClinical & Experimental Metastasis, 2009
- Tumor recurrence and malignant progression of gangliogliomasCancer, 2008
- A Pilot Study with Very Low-Intensity, Intermediate-Frequency Electric Fields in Patients with Locally Advanced and/or Metastatic Solid TumorsOnkologie, 2008
- Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumorsProceedings of the National Academy of Sciences, 2007
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002